SAT0079 Tumour Necrosis Factor Alpha Inhibitor Treatment Normalises Hand Bone Loss in a Minority of Rheumatoid Arthritis Patients Treated in Clinical Practice. Results from the Copenhagen Osteoarthritis Study and the Danbio Registry

2015 ◽  
Vol 74 (Suppl 2) ◽  
pp. 677.1-677
Author(s):  
L. Ørnbjerg ◽  
M. Østergaard ◽  
T. Jensen ◽  
L. Hyldstrup ◽  
P. Bach-Mortensen ◽  
...  
1994 ◽  
Vol 12 (2) ◽  
pp. 127-133 ◽  
Author(s):  
Victor A. Danis ◽  
Michelle Millington ◽  
Valentine Hyland ◽  
Ron Lawford ◽  
Qirong Huang ◽  
...  

The frequency of the uncommon allele (TNF2) of a polymorphism in the promoter region of the tumour necrosis factor alpha (TN Fα) gene in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) was found to be 3 times that of the normal anglo-saxon population. In SLE patients, this allele was strongly associated with HLA-DR3 expression and was also more frequent in patients who did not have malar rash. Functional studies of normal monocyte cytokine production in vitro showed that this genotype was associated with increased IL-1α protein production but there were no differences in the production of TNFα protein.


2015 ◽  
Vol 22 (Suppl 1) ◽  
pp. A62.1-A62
Author(s):  
O García Molina ◽  
MA Fernandez De Palencia Espinosa ◽  
V Arocas Casañ ◽  
F Mendoza Otero ◽  
J Mateo Carmona ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document